SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SSgA Active Trust - SPDR S&P 500 ETF Trust

The SPDR S&P 500 ETF Trust is trending as President Trump's threats of new tariffs on European nations over Greenland escalate geopolitical tensions, leading to a risk-off market sentiment. The community is divided, with some anticipating a significant market pullback, while others view it as a 'buy the dip' opportunity, also noting a Japan-led bond sell-off as a contributing factor. This environment is fueling discussions about broader market volatility and a flight to safe-haven assets.

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBio is trending following constructive discussions with the FDA regarding a resubmission path for ANKTIVA in bladder cancer, complemented by significant international approvals and strategic partnerships like those recently established in Saudi Arabia for broader cancer indications. This development, coupled with high short interest, is fueling widespread community excitement about a potential paradigm shift in oncology and intense speculation regarding a short squeeze amidst growing calls for expedited access to these innovative treatments.

Invesco Capital Management LLC - Invesco QQQ Trust Series 1

QQQ is actively trending amid escalating US-EU trade tensions driven by President Trump's tariff threats over Greenland, sparking a widespread market sell-off and global risk-off sentiment. The investment community is sharply divided between those anticipating a deeper correction for technology and growth stocks and fervent "buy the dip" proponents. Immediate market focus remains on an upcoming Supreme Court ruling regarding tariff authority and a heavy week of earnings reports, amplifying uncertainty.

Novavax, Inc. Is a biotechnology company, which engages in the discovery, development, and commercialization of recombinant vaccines. The company was founded in 1987 and is headquartered in Gaithersburg, MD.

Novavax, Inc.

Novavax Inc

Novavax is a major talking point following its J.P. Morgan conference appearance, where investors are eagerly seeking clarity on its strategy for advancing the Matrix-M adjuvant technology and securing new collaborations. Community sentiment is sharply focused on management's pace in realizing pipeline potential, including a recent Pfizer agreement and ongoing Sanofi ventures, with an activist investor's growing stake and significant short interest adding to the intense market watch.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+ and TMTG News. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

Trump Media & Technology Group Corp. (DJT) is seeing heightened conversation due to recent developments surrounding Trump's assertive stance on Greenland and reactions to a perceived Nobel Peace Prize snub, which has sparked discussions of new tariffs on European nations. The community is actively debating the potential for increased market volatility, geopolitical instability, and the broader economic ramifications of these actions. This ongoing dialogue underscores intense political polarization and its influence on market sentiment.

Corvus Pharmaceuticals, Inc. engages in the development of immune modulator product candidates with the potential to treat solid cancers, T-cell lymphomas, autoimmune diseases, and infectious diseases. Its product pipeline includes B Cell Activator and Anti-CD73, Adenosine Production Inhibitor Anti-CD73, ITK Inhibitor, A2AR Inhibitor, Anti-CXCR2, and A2BR Inhibitor. The company was founded by Richard A. Miller, Peter A. Thompson, Joseph J. Buggy, and Erik Verner on January 27, 2014 and is headquartered in South San Francisco, CA.

Corvus Pharmaceuticals Inc

Corvus Pharmaceuticals is trending after announcing positive data from its placebo-controlled Phase 1 clinical trial of soquelitinib for atopic dermatitis, showing strong efficacy. The community is actively discussing the oral ITK inhibitor's potential in a large market, with many anticipating significant revaluation and partnership opportunities for its novel mechanism of action.

BlackRock Institutional Trust Company N.A. - iShares 20+ Year Treasury Bond ETF

iShares 20+ Year Treasury Bond ETF

TLT is trending amid intense debate surrounding the Federal Reserve's independence, fueled by a federal probe into its Chair and the administration's aggressive policy maneuvers impacting bond markets. Investors are actively discussing whether long-term treasuries offer a crucial hedge against a potential economic slowdown or face further headwinds from escalating national debt and geopolitical uncertainty.

Ardelyx, Inc. is a biopharmaceutical company, which engages in the business of developing and commercializing biopharmaceutical products. The firm is also involved in developing a unique and innovative platform that enables the discovery of new biological mechanisms and pathways to develop potent and efficacious therapies that minimize the side effects and drug-drug interactions frequently encountered with traditional, systemically absorbed medicines. The company was founded by Dominique Charmot, Peter G. Schultz, and Jean M. Frechet in October 2007 and is headquartered in Waltham, MA.

Ardelyx Inc

Ardelyx is trending as investors react to a significant patent extension for its key products until 2041, coupled with a bullish preliminary business update accelerating IBSRELA's path to $1 billion in revenue by 2029 and multiple analyst price target upgrades. The community is buzzing with renewed acquisition speculation and optimism over the company's long-term value, despite ongoing discussions about short-term price fluctuations attributed to market dynamics. This confluence of positive developments has many viewing Ardelyx as a significantly undervalued biotech with strong commercial execution.

AppLovin Corp. engages in the development and operation of a mobile marketing platform. It offers AppDiscovery, MAX, Adjust, and SparkLabs. Its software-based platform caters to mobile application developers to improve the marketing and monetization of applications. The company was founded by Andrew Karam, John Krystynak, and Adam Foroughi in 2011 and is headquartered in Palo Alto, CA.

Applovin Corp - Ordinary Shares - Class A

Applovin Corp

Applovin (APP) is actively trending amid recent allegations of money laundering and illicit financial ties, triggering a sharp sell-off across the stock. Despite this, community sentiment is divided, with many dismissing the claims as a coordinated short attack ahead of strong earnings, while others are seizing the opportunity to buy into the fundamentally strong AI-powered ad platform.

POET Technologies, Inc. engages in the designing, developing, manufacturing and sale of opto-electronic solutions for the sensing, data communications and telecommunications markets. It developed POET Optical Interposer platform, which allows the integration of electronic and photonic devices into a single multi-chip module. The company was founded on November 14, 1985 and is headquartered in Toronto, Canada.

POET Technologies Inc

POET Technologies is gaining significant attention as its patented Optical Interposer platform is seen as crucial for next-generation AI and data center infrastructure, enabling highly efficient and scalable optical interconnects. The community is actively discussing recent product innovation awards and confirmed partnerships, including with Celestial AI (now Marvell), which validate its technology. Anticipation is also building for the imminent disclosure of major institutional investors, signaling strong long-term confidence.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Solana Company (NASDAQ:HSDT) Short Interest Up 71.1% in December

Solana Company (NASDAQ:HSDT - Get Free Report) was the target of a significant increase in short interest in December. As of December 31st, there was short interest totaling 963,146 shares, an...

Solana (NASDAQ:HSDT) Stock Price Up 1.2% - Here's Why

Solana (NASDAQ:HSDT) Trading Up 1.2% - What's Next...

<ul class="summary-bullets"><li>The partnerships extend Solana Company’s on-chain strategy, which includes more than 2.2 million SOL held in custody at Anchorage Digital Bank.&nbsp;</li><li>Solana Company holds about 2.2 million SOL and is the second-largest Solana-based digital asset treasury, after Forward Industries.&nbsp;</li><li>The agreements give HSDT access to platforms that allow it to delegate, stake, and restake its digital assets to earn rewards.&nbsp;</li></ul>Solana Company (HSDT) announced on Thursday that it is expanding its digital asset treasury (DAT) operations and has entered agreements with Helius and Twinstake related to non-custodial staking services.&nbsp;<a href="http://stocktwits.com/symbol/HSDT">HSDT’s stock</a> rose nearly 10% in morning trade, with retail sentiment on Stocktwits trending in ‘extremely bullish’ territory, accompanied by ‘extremely high’ levels of chatter. Meanwhile, Solana led gains among the top 10 cryptocurrencies&nbsp;by market capitalization.&nbsp;<a href="http://stocktwits.com/symbol/SOL.X">Solana’s price</a> rose more than 2.7% in the last 24 hours. However, retail sentiment around the altcoin continued to trend in ‘bearish’ territory.<h2 class="st-heading-2">Broader Push Into On-Chain Solana Exposure</h2>The partnerships extend Solana Company’s on-chain strategy, which includes more than 2.2 million SOL held in custody at Anchorage Digital Bank. The agreements give HSDT access to platforms that allow it to delegate, stake, and restake its digital assets to earn rewards.&nbsp;According to Solscan&nbsp;<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://solscan.io/validator">data</a>, both Twinstake and Helius rank among the top 25 validators on Solana by total tokens staked. The company said services under the agreements include staking, voting with staked tokens, and reporting on token activity.<blockquote>“By staking with industry leaders like Helius and Twinstake, we are strengthening the operational backbone of our SOL holdings while contributing to the resilience and decentralization of the Solana ecosystem.”&nbsp;– Joseph Chee, Executive Chairman, Solana Company</blockquote>Cosmo Jiang, General Partner at Pantera Capital and Board Observer at HSDT, stated that the partnerships enable HSDT to maximize on-chain yield securely and in compliance with institutional standards. “Partnering with top-tier validators trusted by the broader Solana community reinforces our focus on institutional-grade execution and network alignment,” Jiang said.<h2 class="st-heading-2">HSDT’s Pivot From Medical Devices To Solana-Focused Treasury</h2>HSDT is one of the few publicly traded firms in the U.S. holding Solana on its balance sheet. Forward Industries (FORD) remains the largest corporate holder with 6.8 million SOL, while smaller participants include VisionSys AI (VSA) and Ken Griffin-backed DeFi Development (DFDV).Before its pivot in late September, HSDT, formerly Helius Medical Technologies, developed medical devices. The company has since rebranded as Solana Company and repositioned itself as a Solana-focused treasury vehicle.The firm opened a resale window for private investors earlier this week, causing a sharp&nbsp;<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://decrypt.co/345133/solana-company-touts-conviction-investors-gain-right-sell-shares">drop</a> in its stock price as locked-up shares hit the market.Read also:&nbsp;<a href="https://stocktwits.com/news-articles/markets/cryptocurrency/bitcoin-on-track-to-hit-110-00-after-china-says-trade-talks-with-us-set-for-friday/cLG4W8vR3Ap">Bitcoin On Track To Hit $110,00 After China Says Trade Talks With US Set For Friday</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, the Solana Company logo is seen displayed on a smartphone screen. (Photo Illustration by Thomas Fuller/SOPA Images/LightRocket via Getty Images)

Solana Company Expands DAT Operations With Helius, Twinstake Partnerships

The partnerships extend Solana Company’s on-chain strategy, which includes more than 2.2 million SOL held in custody at Anchorage Digital Bank. 

Equity

Shares of The Solana Company (HSDT) dropped as much as 40% in midday trade on Thursday after its treasury token, Solana (SOL), declined more than 5% over the past 24 hours amid broader weakness in the cryptocurrency market.<a href="http://stocktwits.com/symbol/HSDT">HSDT’s stock price</a> fell to an intraday low of $8.65 before recovering to trade around $10 by early afternoon. However, retail sentiment around HSDT’s stock on Stocktwits improved to ‘neutral’ from ‘bearish’ territory.Meanwhile,&nbsp;<a href="http://stocktwits.com/symbol/SOL.X">Solana’s price</a> was trading at around $187, with retail sentiment continuing to trend in ‘bullish’ territory amid ‘high’ levels of chatter.&nbsp;The company announced its pivot to a Solana-holding digital asset treasury (DAT) in late September and has since amassed over 2.2 million SOL tokens. The company has positioned its Solana holdings as part of a broader strategy to integrate blockchain infrastructure and on-chain financial management into its business model.&nbsp;At its peak over the past week, Solana traded near $222, giving Solana Company’s holdings an estimated value of $488 million. Following the crypto market selloff that began Friday, the value of those holdings has fallen to about $413 million, as of the current trading price — a decline of roughly $75 million. In October, the company’s market net asset value (mNAV), dropped from 3.79 to 1.42, according to Blockworks <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://blockworks.com/analytics/treasury-companies/solana-treasury-companies">data.</a><figure class="image"><a class="st-link-external" href="https://blockworks.com/analytics/treasury-companies/solana-treasury-companies" target="_blank" rel="noopener noreferrer nofollow"><img style="aspect-ratio:1124/624;" src="https://news.stocktwits-cdn.com/Solana_Treasury_Companies_Outstanding_m_NAV_png_45cc29da5d.webp" alt="Solana Treasury Companies_ Outstanding mNAV.png" width="1124" height="624"></a><figcaption>Solana Company's Outstanding mNAV | Source:Blockworks Research</figcaption></figure>Other digital asset treasury firms were also in the red during afternoon trade amid the crypto sell-off. Tom Lee-backed Bitmine Immersion (BMNR) fell 3.2% as its native token, Ethereum (ETH), fell more than 2% in the last 24 hours. Similarly, Strategy (MSTR) fell 2.2% on Thursday as Bitcoin’s (BTC) price tumbled 2.1%.&nbsp;Read also:&nbsp;<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://cms.stocktwits.com/admin/content-manager/collection-types/api::article.article/15072">Bitfarms Slides On $300 Million Offering After Rallying To Near 4-Year High, Retail Buzz Stays Elevated</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Solana logo displayed on a phone screen and representation of cryptocurrencies are seen in this illustration photo taken in Krakow, Poland on August 21, 2021. (Photo Illustration by Jakub Porzycki/NurPhoto via Getty Images)

Solana Company Stock Plunges 40% After SOL Price Drop Hits Treasury Value

Solana Company’s holdings of Solana tokens have declined by as much as $75 million over the past week.

Solana Company Stock Plunges 40% After SOL Price Drop Hits Treasury Value 

Solana Company (NASDAQ:HSDT) Selects BitGo as Custodian for SOL Treasury Holdings

Solana Company (NASDAQ:HSDT) (HSDT or the Company), formerly known as Helius Medical Technologies, Inc., today announced it has selected BitGo, the digital asset infrastructure company, to serve as a...

Shares of Solana Company (HSDT) jumped on Monday after the neurotech company announced the pricing of an oversubscribed $500 million private investment in public equity (PIPE) offering, led by Pantera Capital and Summer Capital.The transaction also <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://ir.heliusmedical.com/news-releases/news-release-details/helius-nasdaqhsdt-partnership-pantera-capital-and-summer-capital">includes</a> $750 million in potential funding through stapled warrants, exercisable at $10.134 per share for a period of three years, with the shares priced at $6.881. The closing is expected on or around September 18, subject to customary conditions.Proceeds from the deal will fund Solana Co.’s new digital asset treasury strategy, anchored by Solana (SOL), the native token of the Solana blockchain. SOL will serve as the company’s primary treasury reserve asset. Solana Co plans to acquire SOL in the open market and establish dedicated treasury operations, while continuing to allocate funds to working capital and general corporate purposes.The company expects to significantly scale its SOL holdings over the next 12–24 months and will evaluate opportunities to generate yield through staking, lending, and broader decentralized finance activities.The strategy will be overseen by incoming Executive Chairman Joseph Chee, Founder of Summer Capital and former Head of Investment Banking Asia at UBS, alongside Cosmo Jiang, General Partner at Pantera Capital, as Board Observer, and Dan Morehead, Founder and Managing Partner of Pantera, as Strategic Advisor.On Stocktwits, retail sentiment around <a href="https://stocktwits.com/symbol/HSDT">HSDT stock</a> stayed within ‘extremely bullish’ territory over the past 24 hours, while message volume stayed at ‘extremely high’ levels. Shares of the company jumped 169% at the time of writing.<figure class="image"><img style="aspect-ratio:581/58;" src="https://news.stocktwits-cdn.com/Screenshot_2025_09_15_at_11_06_42_AM_png_b58b3f6ca1.webp" alt="HSDT's Sentiment Meter and Message Volume as of 11:07 a.m. ET on Sept. 15 2025 | Source: Stocktwits" width="581" height="58"><figcaption>HSDT's Sentiment Meter and Message Volume as of 11:07 a.m. ET on Sept. 15 2025 | Source: Stocktwits</figcaption></figure>A Stocktwits user cheered the announcement.<stembedurl>https://stocktwits.com/Thess5/message/628694520</stembedurl>HSDT stock is down by 96% this year.Read also: <a href="https://stocktwits.com/news-articles/markets/equity/stocks-making-the-biggest-moves-today-september-15/chwwhFnRdUn">Tesla, Alphabet, Intel, BitMine, Nvidia: Stocks Making The Biggest Moves Today</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.Editor's Note: The story has been updated to reflect the firm's change of name to Solana Company.

Rising stock market chart on a trading board background.

Solana Company Stock Rockets 169% After Firm Raises $500M To Make SOL Its Primary Treasury Asset: Retail Cheers The Deal

Solana Company plans to acquire SOL in the open market and establish dedicated treasury operations, while continuing to allocate funds to working capital and general corporate purposes.

Solana Co. is a neurotech company in the medical device industry that focuses on neurological wellness. The firm develops, licenses and acquires non-invasive platform technologies that amplify the brain’s ability to heal itself and reduce symptoms of neurological disease or trauma. It engages in the development of the investigational portable neuromodulation stimulator, that delivers neurostimulation via the tongue which has been shown in clinical studies to enhance the effectiveness of physical exercises in people with neurological symptoms from disease or trauma such as mild-to-moderate traumatic brain injury. The company was founded on March 13, 2014 and is headquartered in Newtown, PA.

Current Price	$3.30
Prev Close	$3.10
Open	$3.15
Dividend Yield	0.00%
50-Day Moving Average	$3.69
Beta	1.45
Avg. Volume	554,750.45
PE Ratio	0.00

52-Week High	$1,200.00
52-Week Low	$2.62
Market Capitalization	$136.29M
EPS (Annual)	-$3,249.89
Price to Book	-0.87
Revenue Per Employee	$24,761.90
Enterprise Value/EBITDA	N/A

HSDT
Solana Co

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest HSDT News

HSDTSolana Co